MarketInOut Stock Screener Log In | Sign Up
 

Ensysce Biosciences Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/16/2026 16:00
Ensysce Biosciences Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization11 mln
Float18.54 mln
Earnings Date11/16/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-9.88
Highly reliable

Relative Strength

99 / 100
Top performer

Pre-Tax Margin

-280%
Severely loss-making

ROE

-944
Deeply negative

Altman Z-Score

-81.05
Deeply distressed

Business Description

Ensysce Biosciences is a California-based drug development company focused on making opioid pain medications safer by building in protections against misuse, overdose, and addiction. Its lead pain treatment is designed to activate only under normal digestive conditions, while a companion version adds a further safeguard that limits the effect if too many pills are taken at once. The company is also working on treatments for attention deficit disorder and opioid dependency.

Key Fundamentals

EPS-2.46
ROE-944
RPS0.68
ROIC-1,790
ROA-296
Interest Cover-792
EBITDA, mln-12.59
EV / EBITDA-0.51
EV / EBIT-0.51
Revenue, mln4.50
EV / Revenue1.43

Quote Details

Last 0.5183
Change -0.0796 (-13.31%)
Open 0.5871
Volume 489,908
Turnover 253,919
Average Volume 574,318

Financial Ratios

Pre-Tax Profit Margin-280
Current Ratio0.60
Price / Sales0.44

Financial Strength

Altman Z-Score-81.05
Piotroski F-Score 4 / 9
Beneish M-Score-9.88
Short Ratio2.14
Short % of Float5.56

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -1.65% 49 / 100   
1 Month 14.54% 97 / 100   
2 Months 88.13% 99 / 100   
6 Months 3.66% 69 / 100   
1 Year -79.02% 9 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us